“…Although SIX1 expression in most adult tissues is rare, upregulation of this transcription factor has been detected in over ten different cancers, including tumors that arise from skeletal muscle tissue, called rhabdomyosarcoma (RMS) (Christensen et al, 2008;Patrick et al, 2013;Yu et al, 2004). Interestingly, the expression of miR30a decreases with the progression of lymphoma, leukemia, lung, ovarian, breast and colon cancer (Cheng et al, 2012;González-Gugel et al, 2013;Guan et al, 2012;Lee et al, 2012;Liu et al, 2013;Ma et al, 2012;Võsa et al, 2013), all cancers in which SIX1 overexpression has been detected (Behbakht et al, 2007;Ford et al, 1998;Mimae et al, 2012;Ono et al, 2012;Wang et al, 2011).…”